Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Fosgonimeton Provides Congruent Improvements on Neurodegeneration Biomarkers, Significantly Correlating With Composite Clinical Score of Cognition and Function in Alzheimer’s Disease